All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Abbott Laboratories Inc. has won a nod for MR-conditional labeling on some of its most widely used high voltage devices. The FDA-approved labeling is for the Quadra Assura Mp Cardiac Resynchronization Therapy Defibrillator (CRTD) and Fortify Assura implantable cardioverter defibrillator (ICD).